Expression and functional studies of genes in the DGS/VCFS deleted regions

面心速度综合征（VCFS）是一种常见的常染色体显性遗传病。在VCFS患者中观察到的几种最常见的异常至少部分可以解释为神经嵴细胞迁移或分化所需的一种或多种基因的扰动。然而，在22 q11缺失患者中观察到的其他异常与神经嵴细胞迁移或分化没有明显相关性。例如，大量22q11.2缺失的患者患有泌尿生殖系统异常，大多数患者表现出轻度至重度发育迟缓。虽然单个基因的单倍不足可以解释在这些患者中观察到的广泛和高度可变的表型，但这种复杂的疾病也可能是由于几个基因的表达减少。上一个供资周期的工作导致了关键区域的完整物理图谱和多个基因的鉴定。虽然已经从该区域分离出许多基因，但迄今为止进行的研究尚未提供任何一个基因直接负责DGS/VCFS中观察到的所有特征的有力证据。在这个项目中，我们建议通过表达和功能分析来表征选定的基因，以确定它们在这种疾病的病因学中的作用。这将有助于确定蛋白质水平降低在综合征发病机制中的作用。我们推测，可能有序列在22 q11缺失区域，有一个全球性的影响转录。因此，建议实验来确定重排是否破坏影响DGS/VCFS相关基因表达的调控元件。最后，我们建议筛选一组没有22 q11缺失的患者，以检测22 q11和其他染色体区域的候选基因突变。这些研究将为我们对DGS/VCFS的分子理解做出重大贡献。

Velocardiofacial syndrome (VCFS) is a common, autosomal dominant genetic disorder. Several of the most frequent abnormalities observed in patients with VCFS can be explained, at least in part, by perturbation of a gene, or genes, required for neural crest cell migration or differentiation. However, additional abnormalities observed in the 22q11 deleted patients are not as clearly associated with neural crest cell migration or differentiation. For example, a significant number of patients with 22q11.2 deletions have genitourinary abnormalities and the majority of patients exhibit mild to severe developmental delay. While haploinsufficiency for a single gene could explain the broad and highly variable phenotypes seen in these patients, it is also possible that this complex disorder is due to reduced expression of several genes. Work in the previous funding cycle led to a complete physical map of the critical region and the identification of multiple genes. While numerous genes have been isolated from this region, studies performed thus far have not provided strong evidence for any one gene being directly responsible for all of the features seen in DGS/VCFS. In this project we propose to characterize selected genes by expression and functional analysis to determine their role in the etiology of this disorder. This will help determine the effect of reduced levels of the proteins in the pathogenesis of the syndrome. We hypothesize that there may be sequences in the 22q11 deleted region that have a global effect on transcription. Thus, experiments are proposed to determine whether the rearrangements are disrupting regulatory elements that influence the expression of DGS/VCFS-related gene. Finally, we propose to screen a cohort of patients who do not have deletions of 22q11 for mutations in candidate genes from 22q11 and other chromosomal regions. These studies should make a significant contribution to our molecular understanding of DGS/VCFS.